应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SCNX Scienture Holdings, Inc.
休市中 11-13 16:00:00 EST
2.90
-0.11
-3.65%
盘后
2.90
+0.00
0.00%
19:30 EST
最高
2.94
最低
2.83
成交量
4,579
今开
2.94
昨收
3.01
日振幅
3.82%
总市值
476.34万
流通市值
376.66万
总股本
164.26万
成交额
1.34万
换手率
0.35%
流通股本
129.88万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Scienture携手分销伙伴,将Rezenopy™商业版图拓展至成瘾治疗中心
美股速递 · 09-22
Scienture携手分销伙伴,将Rezenopy™商业版图拓展至成瘾治疗中心
Scienture Holdings Q2 2026业绩出炉:营收环比暴增约510%,运营表现显著改善
美股速递 · 08-14
Scienture Holdings Q2 2026业绩出炉:营收环比暴增约510%,运营表现显著改善
Scienture宣布Rezenopy™正式上市,首批订单已交付——这是FDA批准的最高剂量纳洛酮鼻喷雾剂
美股速递 · 08-12
Scienture宣布Rezenopy™正式上市,首批订单已交付——这是FDA批准的最高剂量纳洛酮鼻喷雾剂
Scienture公布2026年第一季度财报:营收强劲增长,毛利率显著扩张
美股速递 · 05-18
Scienture公布2026年第一季度财报:营收强劲增长,毛利率显著扩张
公司概况
公司名称:
Scienture Holdings, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Scienture Holdings, Inc.于2005年7月15日在特拉华州注册成立。该公司的主要运营子公司是Scienture,LLC。Scienture LLC是一家专业制药公司,专注于心血管(“CVS”)和中枢神经系统(“CNS”)疾病治疗产品的商业化和开发。
发行价格:
--
{"stockData":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":2.9,"timestamp":1794603600000,"preClose":3.01,"halted":0,"volume":4579,"hourTrading":{"tag":"盘后","latestPrice":2.9,"preClose":2.9,"latestTime":"19:30 EST","volume":115,"amount":320.3182,"timestamp":1794616201690,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03654485049833883,"floatShares":1298828,"shares":1642565,"eps":-50.75,"marketStatus":"休市中","change":-0.11,"latestTime":"11-13 16:00:00 EST","open":2.94,"high":2.94,"low":2.825,"amount":13385.63593,"amplitude":0.038206,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-50.75,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":3.01,"preHourTrading":{"tag":"盘前","latestPrice":2.96,"preClose":3.01,"latestTime":"08:51 EST","volume":9,"amount":26.64,"timestamp":1794577877245,"change":-0.05,"changeRate":-0.016611,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.9,"preClose":2.9,"latestTime":"19:30 EST","volume":115,"amount":320.3182,"timestamp":1794616201690,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5006560255863897},"requestUrl":"/m/hq/s/SCNX/wiki","defaultTab":"wiki","newsList":[{"id":"1161955625","title":"Scienture携手分销伙伴,将Rezenopy™商业版图拓展至成瘾治疗中心","url":"https://stock-news.laohu8.com/highlight/detail?id=1161955625","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161955625?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:18","pubTimestamp":1790079505,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.近日宣布,已与一家分销合作伙伴达成协议,旨在扩大Rezenopy™在成瘾治疗领域的商业覆盖范围。这一战略举措,标志着该公司正着力深化其产品在专业医疗渠道的渗透力,进一步巩固市场地位。通过此番合作,Rezenopy™将更便捷地触达相关治疗机构,从而为有需要的患者群体提供更高效的支持。此举不仅彰显了Scienture对拓展业务版图的坚定决心,也反映了其在专业健康领域持续布局的长期愿景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112132128","title":"Scienture Holdings Q2 2026业绩出炉:营收环比暴增约510%,运营表现显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1112132128","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112132128?lang=zh_cn&edition=full","pubTime":"2026-08-14 20:09","pubTimestamp":1786709350,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.今日公布了2026年第二季度财务报告。与第一季度相比,公司营收实现了令人瞩目的飞跃——环比增幅高达约510%。与此同时,运营绩效也呈现出显著的优化态势。具体而言,Scienture在第二季度不仅成功扭转了此前季度相对疲软的增长态势,更在成本控制与业务结构优化上取得了实质性突破。尽管当前宏观环境仍存变数,但Scienture凭借这一季度的超预期表现,已向投资者展示了其强劲的成长韧性与执行能力。此次财报,或将成为公司估值重塑的关键催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198130031","title":"Scienture宣布Rezenopy™正式上市,首批订单已交付——这是FDA批准的最高剂量纳洛酮鼻喷雾剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1198130031","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198130031?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:06","pubTimestamp":1786536370,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.今日发布公告,正式启动Rezenopy™的商业化上市,并已完成首批采购订单的履约交付。Rezenopy™作为美国食品药品监督管理局(FDA)批准的最高剂量纳洛酮鼻喷雾剂,标志着公司在阿片类药物过量逆转领域迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197083931","title":"Scienture公布2026年第一季度财报:营收强劲增长,毛利率显著扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=1197083931","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197083931?lang=zh_cn&edition=full","pubTime":"2026-05-18 20:39","pubTimestamp":1779107951,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.发布了2026年第一季度财务业绩及业务进展。报告期内,公司实现了显著的营收增长,同时毛利率亦获得有力扩张,展现出强劲的业务发展势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scientureholdings.com","stockEarnings":[{"period":"1week","weight":-0.072},{"period":"1month","weight":-0.1343},{"period":"3month","weight":-0.7473},{"period":"6month","weight":-0.7122},{"period":"1year","weight":-0.8274},{"period":"ytd","weight":-0.7725}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Scienture Holdings, Inc.于2005年7月15日在特拉华州注册成立。该公司的主要运营子公司是Scienture,LLC。Scienture LLC是一家专业制药公司,专注于心血管(“CVS”)和中枢神经系统(“CNS”)疾病治疗产品的商业化和开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.119636},{"month":2,"riseRate":0.333333,"avgChangeRate":0.150517},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.073293},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.066728},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.090449},{"month":6,"riseRate":0.857143,"avgChangeRate":0.461559},{"month":7,"riseRate":0.714286,"avgChangeRate":0.094869},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.141065},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.088428},{"month":10,"riseRate":0,"avgChangeRate":-0.209646},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.071791},{"month":12,"riseRate":0,"avgChangeRate":-0.185859}],"exchange":"NASDAQ","name":"Scienture Holdings, Inc.","nameEN":"Scienture Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Scienture Holdings, Inc.(SCNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Scienture Holdings, Inc.,SCNX,Scienture Holdings, Inc.股票,Scienture Holdings, Inc.股票老虎,Scienture Holdings, Inc.股票老虎国际,Scienture Holdings, Inc.行情,Scienture Holdings, Inc.股票行情,Scienture Holdings, Inc.股价,Scienture Holdings, Inc.股市,Scienture Holdings, Inc.股票价格,Scienture Holdings, Inc.股票交易,Scienture Holdings, Inc.股票购买,Scienture Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Scienture Holdings, Inc.(SCNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}